These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Reversible cardiomyopathy induced by interferon. Sonnenblick M; Rosenmann D; Rosin A BMJ; 1990 May; 300(6733):1174-5. PubMed ID: 2346805 [No Abstract] [Full Text] [Related]
44. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon]. Eisenburg J; Caselmann W; Eder M; Pape GR Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536 [No Abstract] [Full Text] [Related]
45. Multiple sclerosis and human interferon alfa. Coyle JT JAMA; 1989 Nov; 262(19):2684. PubMed ID: 2624644 [No Abstract] [Full Text] [Related]
46. Induction of acute corneal allograft rejection by alpha-2 interferon. Jacobs AD; Levenson JE; Golde DW Am J Med; 1987 Jan; 82(1):181-2. PubMed ID: 3541600 [TBL] [Abstract][Full Text] [Related]
47. Mental depression, acute infection and coma in a patient treated with interferon-alpha. Russo D; Zuffa E; Bandini G; Baccarani M; Tura S Haematologica; 1989; 74(2):228. PubMed ID: 2501183 [No Abstract] [Full Text] [Related]
48. Optic neuritis caused by interferon-beta administration. Okuma H; Kawamura Y; Ohnuki Y; Takagi S Intern Med; 2008; 47(19):1759. PubMed ID: 18827434 [No Abstract] [Full Text] [Related]
53. A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy. Sasso FC; Carbonara O; Di Micco P; Coppola L; Torella R; Niglio A Br J Clin Pharmacol; 2003 Aug; 56(2):238-9. PubMed ID: 12895200 [No Abstract] [Full Text] [Related]
54. Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides. Braathen LR; Stavem P BMJ; 1989 Jun; 298(6689):1713. PubMed ID: 2503190 [No Abstract] [Full Text] [Related]
55. Recombinant interferon-alpha-induced chorea and frontal subcortical dementia. Moulignier A; Allo S; Zittoun R; Gout O Neurology; 2002 Jan; 58(2):328-30. PubMed ID: 11805273 [No Abstract] [Full Text] [Related]
56. [Exacerbation of psoriasis during alpha-interferon therapy]. Hartmann F; von Wussow P; Deicher H Dtsch Med Wochenschr; 1989 Jan; 114(3):96-8. PubMed ID: 2912680 [TBL] [Abstract][Full Text] [Related]
57. AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1. He C; Li H; Viollet B; Zou MH; Xie Z Diabetes; 2015 Dec; 64(12):4285-97. PubMed ID: 25858560 [TBL] [Abstract][Full Text] [Related]
58. Alpha recombinant interferon in the treatment of mycosis fungoides (MF). Tura S; Mazza P; Zinzani PL; Ghetti PL; Poletti G; Gherlinzoni F; Montagnani A; Criscuolo D Haematologica; 1987; 72(4):337-40. PubMed ID: 3117634 [No Abstract] [Full Text] [Related]
59. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma. Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730 [TBL] [Abstract][Full Text] [Related]
60. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma. Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]